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Summary
Quinine (QN) remains effective against 
 
Plasmodium
falciparum
 
, but its decreasing efficacy is documented
from different continents. Multiple genes are likely to
contribute to the evolution of QN resistance. To locate
genes contributing to QN response variation, we have
searched a 
 
P. falciparum
 
 genetic cross for quantitative
trait loci (QTL). Results identify additive QTL in seg-
ments of chromosomes (Chrs) 13, 7 and 5, and pair-
wise effects from two additional loci of Chrs 9 and 6
that interact, respectively, with the QTL of Chrs 13 and
7. The mapped segments of Chrs 7 and 5 contain 
 
pfcrt
 
,
the determinant of chloroquine resistance (CQR), and
 
pfmdr1
 
, a gene known to affect QN responses. Asso-
ciation of 
 
pfcrt
 
 with a QTL of QN resistance supports
anecdotal evidence for an evolutionary relationship
between CQR and reduced QN sensitivity. The Chr 13
segment contains several candidate genes, one of
which (
 
pfnhe-1
 
) encodes a putative Na
 
+
 
/H
 
+
 
 exchanger.
A repeat polymorphism in 
 
pfnhe-1
 
 shows significant
association with low QN response in a collection of
 
P. falciparum
 
 strains from Asia, Africa and Central and
South America. Dissection of the genes and modifiers
involved in QN response will require experimental
strategies that can evaluate multiple genes from dif-
ferent chromosomes in combination.
Introduction
 
Quinine (QN), an alkaloid from cinchona bark, is a critical
and widely used drug because of its efficacy against
severe and chloroquine-resistant (CQR) malaria (World
Health Organization, 2000). Yet the status of this drug is
in jeopardy because of decreases in the dose responsive-
ness of 
 
Plasmodium falciparum
 
 infections in regions of
south-east Asia, South America and Africa (Pukrittayaka-
mee 
 
et al
 
., 1994; Jelinek 
 
et al
 
., 1995; Segurado 
 
et al
 
.,
1997).
Reports that decreased QN sensitivity can be asso-
ciated with resistance to other structurally related
drugs such as mefloquine, halofantrine and chloro-
quine (CQ) have led to suggestions that some herita-
ble determinants of drug response may be shared
(Simon 
 
et al
 
., 1986; Warsame 
 
et al
 
., 1991; Basco and
Le Bras, 1992; Brasseur 
 
et al
 
., 1992). Work in recent
years has pointed to two such genes. One is the
 
pfmdr1
 
 gene that encodes a 
 
P. falciparum
 
 P-glycopro-
tein-like protein (Pgh-1) implicated in mefloquine and
halofantrine resistance, and also a possible modulator
of the CQR phenotype (Cowman 
 
et al
 
., 1994; Reed
 
et al
 
., 2000). The other is 
 
pfcrt
 
, the actual determinant
of CQR, which can carry mutations associated with
stereospecific changes in quinine and quinidine
responses (Fidock 
 
et al
 
., 2000; Cooper 
 
et al
 
., 2002).
Although selection and transfection experiments have
implicated these genes in QN response, their relative
contribution to the trait and the way in which they
interact with each other and additional genes to
generate the specific drug response have not been
elucidated.
QN nevertheless remains clinically effective
against CQR and mefloquine-resistant 
 
P. falci-
parum
 
. These observations and the different levels
of QN susceptibility among CQR parasites indicate
that the QN phenotype is complex and is probably
affected by other genes in addition to 
 
pfmdr1
 
 and
 
pfcrt
 
 (Mu 
 
et al
 
., 2003). Searches for loci carrying
these genes are possible through statistical meth-
ods developed to dissect complex quantitative trait
loci (QTL) (Lander and Botstein, 1989; Paterson,
1995; Sen and Churchill, 2001). 
 
P. falciparum
 
genetic crosses can be subjected to genome-wide
scans for individual QTL-containing genes that affect
the resistance phenotype.
Here, we report a QTL analysis of QN responses inher-
ited in cloned parasite progeny from a 
 
P. falciparum
 
 cross.
We address the genetic determinants of the QN
responses of these parasites, including three additive and
two pairwise QTL interactions.
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Results
 
Quantitative drug response traits of the HB3 
 
¥
 
 Dd2 
parents and progeny
 
The parasites for this study were taken from the 
 
P. falci-
parum
 
 genetic cross between HB3, a CQ-sensitive (CQS)
clone from Central America, and Dd2, a CQR clone of
south-east Asian provenance (Wellems 
 
et al
 
., 1990).
Table 1 summarizes quantitative traits of the QN and CQ
responses of the HB3 and Dd2 parent clones, including
their QN and CQ IC
 
50
 
 and IC
 
90
 
 values, response slope
parameters (Hill 3 curve-fit ‘b’) and IC
 
90
 
 values after vera-
pamil (VP) chemosensitization. The values for the Dd2
clone are in the range of QN susceptibilities that our
assays typically yield for culture-adapted parasites from
areas where difficulties with QN treatment have been
reported, including the W2 and W2-MEF ancestors of the
Dd2 clone and other drug-resistant parasite lines from the
Amazon and Indochina (Oduola 
 
et al
 
., 1988; Pukrittayaka-
mee 
 
et al
 
., 1994; Zalis 
 
et al
 
., 1998; Mu 
 
et al
 
., 2003; Pick-
ard 
 
et al
 
., 2003). The response curves and Hill slope b-
parameters of QN response for each parent were repro-
ducible with high precision in more than 50 separate [
 
3
 
H]-
hypoxanthine incorporation assays. The mean b-parame-
ters did not differ significantly between the HB3 and Dd2
clones (2.2 and 2.3, respectively, for QN).
Quantitative trait values for the QN and CQ responses
of 35 independent recombinant progeny from the
HB3 
 
¥
 
 Dd2 cross, based on the results of 7–22 separate
assays, are provided in 
 
Supplementary material
 
(Table S1). The QN b-parameters for the progeny were
found to range from a low of 1.5 to a high of 3.0, well
outside the parental values and indicating heritable com-
ponents in the QN responses that impact the shape of the
dose–response curves and, consequently, the relative
information content of IC
 
90
 
 and IC
 
50
 
 values. Because
median IC
 
90
 
 values are more sensitive to slope variations,
these were used for subsequent QTL analyses to ensure
that this curve information was included in the dose–
response measure. The QN and CQ IC
 
90
 
 values of the
HB3 and Dd2 parents and progeny are plotted in Fig. 1.
CQ response values (
 
y
 
-axis) clearly demonstrate the
effect from 
 
pfcrt
 
, i.e. there is a clear gap separating the
CQ IC
 
90
 
 values of CQS from CQR parasites (Fig. 1A). No
such gap is evident for the QN responses, which are
instead spread across a continuous range that extends to
either side of the low (HB3) and high (Dd2) parent QN IC
 
90
 
values. Considerable overlap is evident in the QN
responses of CQS and CQR progeny, indicating a com-
plex QN response trait involving multiple genes.
The QN IC
 
90
 
 values of the parasites were also examined
 
Table 1.
 
Drug response traits of the HB3 and Dd2 
 
P. falciparum
 
clones.
 
a
 
Trait Dd2 (
 
n
 
 = 65) HB3 (
 
n
 
 = 53)
QN IC
 
50
 
350 (334–368) 115 (110–120)
QN IC
 
90
 
924 (826–1038) 382 (344–424)
QN-VP IC
 
90
 
395 (352–444) 393 (355–433)
QN slope b (Hill)  2.3 (2.1–2.5)  2.2 (2.0–2.4)
CQ IC
 
50
 
433 (417–448) 25 (24–26)
CQ IC
 
90
 
735 (665–811) 44 (40–49)
CQ-VP IC
 
90
 
247 (230–266) 44 (41–49)
CQ slope b (Hill)  4.0 (3.5–4.5)  4.3 (3.5–5.0)
 
a.
 
QN and CQ responses of clones derived from curve-fitted values
(nM) from combined data of 
 
n
 
 dose–response assays. Confidence
intervals (95%) are shown in parentheses. QN-VP IC
 
90
 
 and CQ-VP
IC
 
90
 
 indicate responses to CQ and QN in the presence of 0.89 
 
m
 
M
VP. The slope of QN response curve (QN slope) is the b-parameter
calculated from the Hill 3 curve-fit equation.
 
Fig. 1.
 
QN versus CQ responses of the HB3 
 
¥
 
 Dd2 parents and 
progeny in the absence and presence of VP.
A. In the absence of VP, the large gap distinguishing the CQR from 
the CQS progeny is determined by inheritance of the 
 
pfcrt
 
 gene.
B. Chemosensitization by VP of QN and CQ responses occurs in 
CQR but not in CQS progeny. Each of the progeny data points was 
obtained from 7 to 22 independent dose–response assays. Results 
from CQR clones are shown as filled circles; results from CQS clones 
are shown as open circles. A concentration of 0.89 
 
m
 
M VP was used 
in the chemosensitization experiments.
A
B
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for shifts in the presence of VP, a compound that potenti-
ates the effect of CQ on CQR parasites only (Martin 
 
et al
 
.,
1987). The results show 30–70% VP chemosensitization
of the QN response (a shift to the left in the dose–
response curve) for the CQR but not the CQS parasites
(Fig. 1B). This effect of VP on QN response was strictly
associated with the CQR phenotype and the 
 
pfcrt
 
 mutant
allele, irrespective of the relative QN IC
 
90
 
 values.
Chemosensitization of the QN response by VP did not
occur in any of the CQS progeny.
 
Primary and secondary scans for additive QTL associated 
with drug response
 
To search for chromosome regions involved in drug
responses of the HB3 
 
¥
 
 Dd2 cross, we used the
Pseudomarker QTL analysis package (Sen and Churchill,
2001) to scan the 35 progeny for phenotype associations
with markers in the segregation tables of our reported
5 cM genome-wide linkage map (Su 
 
et al
 
., 1999) (http://
www.ncbi.nlm.nih.gov/Malaria/Mapsmarkers/PfSegData/
segdata.html). The results of these scans indicated that
most of the QN response variation can be attributed to
two main additive QTL: 35% to a chromosome (Chr) 13
peak centred on the C13M56 marker, and another 30%
to a Chr 7 peak centred on the 
 
pfcrt
 
 gene (Fig. 2A).
After accounting for main effects of the Chr 7 and Chr
13 loci, we searched the remaining unassigned fraction of
QN response variation by secondary scans of the residual
variation (Doerge and Churchill, 1996). These scans
revealed a Chr 5 QTL that had not been evident in the
primary scan and accounted for 30% of the remaining
fraction (10.5% of total response variation). The peak
height corresponding to this secondary additive QTL
approaches the permutation-based significance threshold
of 
 
P
 
 = 0.05 (Fig. 2B). The 
 
pfmdr1
 
 gene, previously asso-
ciated with QN response in several studies (Reed 
 
et al
 
.,
2000; Babiker 
 
et al
 
., 2001), resides within this peak near
the B5M86 marker. Of interest, this Chr 5 peak is associ-
ated with increased QN IC
 
90
 
 when it is contributed by HB3,
the more sensitive parent. This is in contrast to the peaks
of Chr 7 and Chr 13, which are associated with increased
QN IC
 
90
 
 when they are contributed by the more resistant
Dd2 parent.
The contribution by the 
 
pfcrt
 
-containing Chr 7 locus to
QN response is evident but relatively small compared with
a recently reported association in genetically heteroge-
neous parasite isolates from around the world (Mu 
 
et al
 
.,
2003). Additionally, the modest effect from this locus on
QN response stands in stark contrast to its control of
nearly all the CQ response variation inherited in the
HB3 
 
¥
 
 Dd2 progeny. Mutations in the Dd2 
 
pfcrt
 
 account
for 
 
>
 
95% of the CQ response variation and are associated
in a sharp peak with LOD 
 
>
 
 20 (Fig. 2C). No statistically
significant additional peaks were identified by secondary
scans of the residual variation in the CQ response after
adjustment for the CQR variance associated with 
 
pfcrt
 
;
however, several smaller peaks that could possibly
account for 20% of this variation included a peak that
aligned with the major QN locus on Chr 13 (Fig. 1; data
not shown). It is possible that incremental contributions
from such minor loci to QN response levels could explain
the slight positive correlation in CQR levels and QN
response (Fig. 1A); such loci could carry incremental
resistance genes or may reflect a complex adaptive role
that different polymorphisms play in the CQR phenotype
conferred by 
 
pfcrt
 
 mutations (Wellems and Plowe, 2001).
 
VP chemosensitization of QN response determined solely 
by 
 
pfcrt
 
 mutations
 
CQR may have features in common with P-glycoprotein-
mediated multiple drug resistance in mammalian tumour
cell lines (Krogstad 
 
et al
 
., 1987; Martin 
 
et al
 
., 1987). Sub-
sequent reports suggested associations between various
quinoline antimalarial responses of 
 
P. falciparum
 
 and
mutations in the 
 
pfmdr1
 
-encoded glycoprotein, Pgh-1
(reviewed by Bray and Ward, 1998); however, VP
chemosensitization of CQR parasites is associated spe-
cifically with 
 
pfcrt
 
 mutations (Fidock 
 
et al
 
., 2000; Cooper
 
et al
 
., 2002; Sidhu 
 
et al
 
., 2002). To test further for genetic
associations to the chemosensitization effect, we per-
formed genome scans on the changes in QN response
produced in the HB3 
 
¥
 
 Dd2 progeny by VP. Results from
these scans showed that the VP chemosensitization of
QN response co-segregated exactly with the Chr 7 peak
containing the Dd2 
 
pfcrt allele (Fig. 2D). Nearly 100% of
the VP affect was assigned to this peak, demonstrating
that, although pfcrt mutations do not alone account for QN
response, they completely determine the VP chemosen-
sitization of QN response. Secondary residual and pair-
wise scans did not detect any effect from the Chr 5
segment carrying pfmdr1 or other QTL elsewhere in the
genome.
Candidate genes from the three additive QTL peaks 
associated with QN response
The pfcrt and pfmdr1 genes that reside in the QTL peaks
of Chrs 7 and 5 have previously been implicated in the
QN responses of P. falciparum. For example, certain
mutations in pfcrt generated by in vitro selection experi-
ments increase sensitivity to QN but reduce sensitivity to
its diastereomer, quinidine (Cooper et al., 2002); the
results of allelic exchange studies have also shown that
pfcrt modifications can affect QN responses (Sidhu et al.,
2002). Additionally, amplification of and site-specific
changes in pfmdr1 can alter QN responses (Cowman
988 M. T. Ferdig et al.
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A
B
C
D
Fig. 2. Main QTL identified by one-dimensional 
genome-wide scans.
A. Plot showing Chr 7 (pfcrt) and Chr 13 
(C13M56) QTL associated with the QN IC90.
B. Chr 5 peak (B5M56) containing the pfmdr1 
gene identified in secondary scan after remov-
ing effects of major QTL associated with mark-
ers C13M56 and pfcrt.
C. Mainscan plot showing the magnitude of the 
effect from the pfcrt gene on CQ response 
(Supplementary material, Table S1) previously 
demonstrated to determine CQR in this cross 
(Fidock et al., 2000).
D. Complete association of the pfcrt peak with 
the VP chemosensitization phenotype, QN-VP 
IC90. 
Markers of the 14 chromosomal linkage groups 
occur sequentially along the horizontal axes. 
LOD scores are plotted as a function of genome 
location. Dashed lines represent threshold val-
ues from 1000 permutations.
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et al., 1994; Reed et al., 2000). The PfCRT and Pgh-1
transporter molecules encoded by these genes probably
underlie the QN response variation that maps to the Chr
7 and Chr 5 QTL peaks, although our study does not
exclude the possibility that QN response might also be
affected by other genes within these peaks.
The Chr 13 QTL peak did not immediately suggest a
polymorphism or gene previously reported to be associ-
ated with malaria drug responses. To search for candidate
genes, we used a Bayesian localization module (Sen
and Churchill, 2001) to generate a posterior distribution
spanning the position of this residual Chr 13 effect
between the subtelomeric region of the chromosome
(ta58 marker) and the proximal 164.5 cM marker, C13M14
[95% confidence interval (CI) ranging from ª170 cM to the
end of the chromosome] (http://www.ncbi.nlm.nih.gov/
Malaria/Mapsmarkers/PfSegData/ch13a.html). The
nucleotide sequence spanning the QTL is a 380 kb
segment (Sanger Center sequence chr13-1 available at
http://plasmodb.org). Approximately 100 predicted genes
reside within this segment (Supplementary material,
Table S2).
Molecules that can affect pH gradients across the mem-
branes of cellular compartments have been proposed to
have a role in responses to CQ and, by extension, to other
quinoline drugs. The A and B subunits of a vacuolar
ATPase (Karcz et al., 1993) and a sodium-hydrogen
exchanger (NHE) (Sanchez et al., 1998; Wunsch et al.,
1998) have been suggested as candidates for such a role.
Evidence for direct involvement of the A subunit in CQR
has been negative, however, and evidence for a primary
role of the NHE in CQR has been refuted (Bray et al.,
1999). We were therefore intrigued by the presence in the
Chr 13 QTL of the PF13_0034 gene, encoding putative
subunit H of a vacuolar ATP synthase, and gene
PF13_0019, encoding a predicted P. falciparum NHE
(PfNHE-1).
To test for an association of QN response variation to
either of these genes, we resequenced PF13_0034 and
PF13_0019 from the HB3 and Dd2 parents, identified
coding frame polymorphisms and surveyed these poly-
morphisms in 71 P. falciparum lines from south-east Asia,
Africa and Central and South America. In the putative ATP
synthase H subunit gene PF13_0034, most lines from
south-east Asia possessed a single codon #8 GGA (Gly)
polymorphism that was largely absent from African and
American lines. The presence or absence of this polymor-
phism did not, however, show any significant association
with QN response levels in our survey.
In contrast to the putative ATP synthase H subunit gene,
sequences of PfNHE-1 showed multiple and complex vari-
ations. In the 71 P. falciparum lines with different QN
responses, these variations were evident as point poly-
morphisms at three separate codons (790, 894, 950) and
as microsatellite variations in three different repeat
sequences (msR1, ms3580, ms4760) (Fig. 3A and B).
Fig. 3. Schematic diagram of PfNHE-1 and alignment of ms4760 microsatellite variations.
A. Features of the full open reading frame include a signal peptide cleavage site (predicted by the SIGNALP program; http://genome.cbs.dtu.dk/
services/) and 12 transmembrane segments in the downstream sequence (MEMSAT program; http://saier-144-37.ucsd.edu/). PfNHE-1 also 
possesses a long C-terminal hydrophilic tail proposed to be a cytoplasmic domain; in related bacterial and mammalian exchangers, this domain 
is thought to modulate transport activity (http://pfam.wustl.edu/ accession no. PF00999; Orlowski and Grinstein, 1997; Hamada et al., 2001). 
Positions of codon polymorphisms 790, 894 and 950 in the hydrophilic tail segment are marked by asterisks; positions of microsatellite variations 
msR1, ms 3580 and ms4760 are labelled. The drawing is scaled to the 1920-amino-acid sequence from the P. falciparum 3D7 gene (Pf13_0019; 
http://www.plasmodb.org/).
B. Alignment of ms4760 sequences from different P. falciparum lines. Microsatellite variation ms4760-1, represented in the South American clone 
7G8 and the south-east Asian clone Dd2, is the form associated with reduced QN sensitivity in the population surveys (Table 2). DNNND repeats 
discussed in the text are highlighted in bold.
A
B
990 M. T. Ferdig et al.
© 2004 Blackwell Publishing Ltd, Molecular Microbiology, 52, 985–997
The three point polymorphisms and microsatellite poly-
morphisms msR1 and ms3580 showed no significant
association with QN response (Table 2). Variable D- and
N-rich repeats encoded by ms4760, however, showed an
identical form (ms4760-1; Fig. 3B) in the relatively
quinine-resistant Dd2 and 7G8 lines from south-east Asia
and South America; this same form also appeared fre-
quently in other parasites with low QN responsiveness
Table 2. Relative QN responses and PfNHE polymorphisms in P. falciparum lines.
Isolate Origin QN responsea
Point polymorphisms Microsatellite polymorphisms
790 894 950 msR1 ms3580 ms4760b
Indo Indochina 3.02 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-7
KMWII Kenya 2.28 GTC AAT GTG TCDNNNMPNNNMSNNN NIH ms4760-1
PC15 Peru 1.75 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
FCB SE Asia 1.61 GTC AAA GGG Not present NIH ms4760-6
JCK Cambodia 1.45 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
V1/S Vietnam 1.26 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
PC09 Peru 1.15 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
C2A Thailand 1.14 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
P31 SE Asia 1.12 GTC AAA GGG Not present NIH ms4760-6
D5 SE Asia 1.12 GTC AAA GGG Not present NIH ms4760-6
Dd2 Indochina 1.00 GTC AAA GGG Not present Not present ms4760-1
TM191c Thailand 0.98 GTC AAA GGG TCDNNNMPNNNMSNNN Not present ms4760-7
TM284 Thailand 0.94 GTC AAA GGG Not present NIH ms4760-1
106/1 Sudan 0.85 GTC AAA GGG Not present NIH ms4760-6
Thai19 Thailand 0.82 GTC AAT GGG Not present NIH ms4760-7
PC26 Peru 0.71 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
DIV17 Brazil 0.67 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
HB3 Honduras 0.63 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-5
DIV14 Brazil 0.57 GTC AAT GGG Not present NIH ms4760-1
ICS Brazil 0.55 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
M97 The Gambia 0.55 GTC AAT GTG Not present NIH ms4760-3
ECP Brazil 0.52 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
PC17 Peru 0.51 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
JAV Colombia 0.50 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
PC49 Peru 0.46 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-6
Fab6 South Africa 0.42 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-8
7G8 Brazil 0.39 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
Thai16 Thailand 0.35 GTC AAA GGG Not present NIH ms4760-1
K39 Kenya 0.35 GTC AAT GTG Not present NIH ms4760-3
123/5 Sudan 0.35 GTC AAA GGG TCDNNNMPNNNMSNNN NIH ms4760-3
128/4 Sudan 0.32 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
9013 Ghana 0.31 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-3
PAD Brazil 0.28 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-3
DIV30 Brazil 0.28 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-3
124/8 Sudan 0.27 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-8
M5 Mali 0.27 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
3D7 Africa 0.25 GTC AAT GTG Not present NIH ms4760-2
S35 Mali 0.23 GTC AAT GGG Not present Not present ms4760-1
M2 R/Mali 0.23 TTC AAT GGG Not present NIH ms4760-1
Fab9 South Africa 0.22 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-6
ECU Ecuador81 0.21 GTC AAT GGG Not present NIH ms4760-7
Haiti Haiti 0.21 GTC AAA GGG TCDNNNMPNNNMSNNN NIH ms4760-1
D10 Papua New Guinea 0.20 TTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-7
REN Sudan 0.17 GTC AAT GTG Not present NIH ms4760-3
9020 Ghana 0.17 GTC AAT GGG Not present Not present ms4760-1
4156 The Gambia 0.17 GTC AAT GGG Not present NIH ms4760-3
T2/c6 Thailand 0.17 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-3
9016 Ghana 0.16 GTC AAT GGG Not present NIH ms4760-3
102/1 Sudan 0.16 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
M190 The Gambia 0.15 GTC AAT GTG Not present NIH ms4760-3
LF4/1 Liberia 0.14 GTC AAT GGG Not present NIH ms4760-1
SL/D6 Sierra Leone 0.14 GTC AAT GGG Not present NIH ms4760-8
MR80 Vietnam 0.13 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-7
PNG3 Papua New Guinea 0.13 GTC AAA GGG TCDNNNMPNNNMSNNN NIH ms4760-7
425 The Gambia 0.13 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
224 The Gambia 0.13 GTC AAT GTG TCDNNNMPNNNMSNNN NIH ms4760-3
713 Guinea Bissau 0.13 GTC AAT GGG Not present NIH ms4760-7
418 The Gambia 0.12 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-3
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from south-east Asia, South America and Africa (Table 2).
Other forms of the ms4760 region were more often found
in the relatively QN-sensitive lines (Table 2). These obser-
vations, and the fact that identical ms4760-1 variations
probably arose independently in the Dd2 and 7G8 drug-
resistant lines from south-east Asia and South America,
led us to examine the ms4760 variations in more detail.
Figure 3B shows an alignment of eight ms4760 types
among the 71 worldwide isolates listed in Table 2. The
insertions and deletions of degenerate repeats in this
alignment occur within an ª150 bp region of the coding
frame. When the parasite isolates were grouped by the
number of DNNND repeats in the ms4760 types, we found
a statistical association with QN response (F3,66 = 3.190,
P = 0.0082). Post hoc tests indicated that this relationship
could be attributed to differences in QN response between
isolates containing one versus two or more repeat units.
When only parasites were evaluated from Asia and South
America, where reduced clinical efficacy of quinine has
been most clearly documented, a relationship of quinine
responses and the number of DNNND repeats was still
observed (F1,30 = 4.485, P < 0.05).
Evidence for loci that interact with the Chr 13 and 
Chr 7 QTL
The complexity of the QN response with respect to the
additive loci of Chrs 13, 7 and 5 and its significant but
incomplete association with PfNHE-1 repeat polymor-
phisms in some parasite lines led us to conduct additional
pairwise searches for interacting QTL. These interaction
effects can reveal QTL that show no effect alone, but
rather have an influence dependent on a second locus.
The pairwise scans, performed as described by Sen and
Churchill (2001), identified significant interactions on the
HB3 ¥ Dd2 background with the main QTL of Chrs 7 and
13 (Fig. 4). These interactions were with chromosomes 6
and chromosomes 9 respectively. In each paired interac-
tion, Chr 6 ¥ Chr 7 and Chr 9 ¥ Chr 13 (Table 3; Fig. 4),
the maximum effect of the main locus shifting the
responses higher was exerted when the interacting locus
was also from the Dd2 parent. No independent main
effects were detected for either of the Chr 6 and 9 loci
alone (Fig. 2A and B), and little impact of the interacting
locus was present if the main QTL was from the HB3
parent (Table 4, coef column; Fig. 4).
These observations suggest that gene interactions
could reflect either co-operative drug response genes or
compensatory mutations selected in the Dd2 parent
clone. Although we do not know how these pairs func-
tion, an observation is possibly relevant: prolonged clon-
ing periods and slow in vitro expansion rates were
observed for the six independent recombinants with the
HB3-type Chr 6 QTL and the Dd2-type Chr 7 QTL (pfcrt),
which raises the possibility that parasite fitness is
affected by this QTL combination. An additional prelimi-
nary complex growth phenotype based on radiolabelled
hypoxanthine (Hx) incorporation as a growth indicator
shows a QTL on the same arm of Chr 13 as the QN
response locus (M. T. Ferdig, unpublished. observation).
Because our dose–response assays rely on Hx incorpo-
ration, we took steps to rule out the possibility that an
assay-specific artifact could be represented in the drug
response QTL scan: we conducted parallel drug assays
from a subset of nine progeny representing the range of
QN responses using the lactate dehydrogenase indicator
of parasite viability (Makler et al., 1993) and the standard
Hx tests (data not shown). We observed no difference in
the association between drug response and marker
C13M56 at the Chr 13 peak using these two methods.
Additionally, QTL mapping of another quinoline-based
antimalarial compound, mefloquine, using the Hx assay
M24 Kenya 0.11 GTC AAT GGG Not present NIH ms4760-3
PNG13 Papua New Guinea 0.11 GTC AAA GGG TCDNNNMPNNNMSNNN Not present ms4760-6
449 The Gambia 0.11 GTC AAT GTG Not present NIH ms4760-3
9021 Ghana 0.11 GTC AAT GGG Not present NIH ms4760-7
433 The Gambia 0.11 GTC AAT GTG Not present NIH ms4760-1
MT/s-1 Thailand 0.11 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-4
Hu425 The Gambia 0.10 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-1
P13 Mali 0.09 GTC AAT GGG Not present NIH ms4760-7
PNG 2 Papua New Guinea 0.08 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-7
PNG4 Papua New Guinea 0.08 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-7
601 The Gambia 0.08 GTC AAT GGG TCDNNNMPNNNMSNNN NIH ms4760-3
434 The Gambia 0.06 GTC AAA GAG TCDNNNMPNNNMSNNN NIH ms4760-3
Camp Malaysia 0.05 GTC AAT GTG TCDNNNMPNNNMSNNN NIH ms4760-3
a. QN responses are expressed as median IC90 values relative to that of the Dd2 control value.
b. Polymorphism types are detailed in Fig. 3.
Isolate Origin QN responsea
Point polymorphisms Microsatellite polymorphisms
790 894 950 msR1 ms3580 ms4760b
Table 2. cont.
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shows no peak in this region of Chr 13 (M. T. Ferdig,
unpublished observation).
Discussion
QN and CQ have related core quinoline structures and
are thought to exert similar toxic effects through interac-
tions with haem in malaria parasite food vacuoles; how-
ever, the historical use of these major antimalarial drugs
and the consequent selection pressure on natural parasite
populations has been distinct. QN has been used in the
form of cinchona bark extracts or purified alkaloid prepa-
A
B C
Fig. 4. Pairwise interactions located by diago-
nally symmetric signals in a two-dimensional 
genome-wide scan.
A. Output from a simultaneous search at 5 cM 
intervals for QTL pairs affecting QN IC90 in the 
HB3 ¥ Dd2 cross. Markers in the 14 linkage 
groups occur in order along the axes. The LOD 
plot for a two-QTL model with interactions is 
displayed below the diagonal; the vertical spec-
trum at the right shows the corresponding LOD 
score colour code. For the pairwise plot below 
the diagonal, the P = 0.05 significance thresh-
old based on 1000 permutations is LOD = 6.9. 
Significant interactions between Chrs 9 and 13 
(LOD = 8.7) and between Chrs 6 and 7 
(LOD = 7.1) are detected as bright yellow sig-
nals (arrows). Above and to the left of the diag-
onal is a plot of the difference in the variance 
between an interactive two-QTL model and a 
non-interactive, additive model. For this plot, a 
nominal cut-off of P = 0.01 was used, and the 
LOD score values were expanded by a factor 
of three to enhance colour detection. Chr 
6 ¥ Chr 7 and Chr 9 ¥ Chr 13 interactions are 
indicated by the red signals diagonally symmet-
rical with those below the diagonal (LOD score 
ª4; arrows).
B and C. Graphic representations of the inter-
active effects between the B5M74 and pfcrt 
markers (Chr 6 ¥ Chr 7) and between the 
C9M57 and C13M56 markers (Chr 9 ¥ Chr 13). 
The inheritance of the Dd2 parent alleles at 
each locus for each interaction results in sub-
stantially higher QN IC90 values than inherit-
ance of other possible allele combinations. 
Corresponding means, standard deviations and 
pairwise comparisons are provided in Table 2.
Table 3. QN IC90 QTL positions and effects.
QTL Chr Effect
Interacting
QTL
Best locus
(cM)a
Peak range
(cM)
Closest
marker
Allele associated with
higher QN IC90
QN IC90 at closest 
marker (mean, SD)b Pc
QN IC90-1 13 Main 180 155–185 C13M56 D 628 (222) 0.0001
QN IC90-2 7 Main 20 10–30 pfcrt D 613 (228) 0.0005
QN IC90-3 5 Main 60 30–75 B5M86 H 548 (231) 0.09d
QN IC90-4 6 Interaction QN IC90-2 25 5–60 B5M74 DxD 718 (203) 0.002
QN IC90-5 9 Interaction QN IC90-1 15 0–50 C9M57 DxD 829 (148) <0.0001
a. Based on a 5 cM grid.
b. Mean QN IC90 values and standard deviations (nM) of progeny containing the indicated marker (or marker combination). Mean QN IC90 for
entire population: 491 ± 219 nM.
c. P-values are based on Student's t-tests comparing group means of progeny containing the D or H marker of the indicated QTL. Interaction
P-values compare the H and D marker group means for each interacting locus (B5M74 or C9M57) when the Dd2 allele is present at the main
effect locus (pfcrt or C13M56 respectively).
d. Calculations with a model incorporating QTL 1 and 2 yielded a P-value of 0.0005 when the H and D B5M86 marker groups were compared.
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rations for four centuries. Malaria parasite strains with
reduced QN sensitivity have been reported from different
malarious regions only since the beginning of the twenti-
eth century (Nocht and Werner, 1910; James et al., 1932;
Clyde et al., 1970). Today, despite the reduced drug sen-
sitivity of some strains in South America and south-east
Asia, all strains remain treatable with dosing regimens that
include an increased QN concentration and a second drug
for radical cure. This pattern is in stark contrast to that of
the global sweep of resistance to CQ: within a few
decades of chloroquine's introduction at the end of the
World War II, fully CQ-resistant P. falciparum strains
spread from at least five foci into nearly all malarious
regions (Wootton et al., 2002; Chen et al., 2003). The slow
progression towards QN resistance reflects more complex
underlying genetic changes in response to the selective
drug pressure than was required for CQR.
Our results assign >95% of the CQR phenotype in the
HB3 ¥ Dd2 cross to a sharp peak on Chr 7 (LOD score
>15; Fig. 2C). This peak contains pfcrt, the determinant of
CQR, as demonstrated by linkage analysis and gene com-
plementation (Fidock et al., 2000), drug selection studies
(Cooper et al., 2002), population studies (Wootton et al.,
2002), direct allelic modification (Sidhu et al., 2002) and
clinical outcome trials (Djimdé et al., 2001). QN response
in the same cross, in contrast, is controlled by multiple
genes and shows no overwhelming influence by a single
locus. Our model incorporates three additive effects, one
of which is the Chr 7 peak containing pfcrt, and two
pairwise interactions from a total of five QTL (Table 4).
Such a multicomponent phenotype in the HB3 ¥ Dd2
cross is consistent with the pattern observed in the field:
QN continues to be effective against CQR and meflo-
quine-resistant P. falciparum in spite of likely subsets of
shared genes controlling these responses. That is, the
pfcrt and pfmdr1 genes associated with CQ and meflo-
quine resistance in a variety of laboratory and field studies
can affect dose–responses and still not lead to high-level
QN-resistant phenotypes, depending on the local selec-
tion history, multigene context and genetic background in
which these mutations function.
While the gene mutations that can influence QN
response in the Chr 7 and Chr 5 loci include pfcrt and
pfmdr1, the Chr 13 peak is new and an effector gene
remains to be identified. Approximately 100 genes are
present within the 95% CI QTL peak, one of which
encodes the probable sodium-hydrogen exchanger
PfNHE-1. A sodium-hydrogen exchanger was previously
postulated to mediate CQR, based on the kinetics of drug
uptake and its inhibition by amiloride derivatives (Sanchez
et al., 1998). Although its relationship to QN response was
not examined, drug resistance in CQR parasites was
attributed to elevated cytoplasmic pH values from a con-
stitutively activated NHE (Wunsch et al., 1998); however,
subsequent experiments using sodium-free buffer that
presumably shut down the exchanger found no depen-
dence of CQ uptake on exogenous sodium. Moreover,
amiloride derivatives were shown to alter CQ uptake by
blocking CQ–haem binding rather than by inhibiting NHE
activity (Bray et al., 1999). This evidence that NHE activity
does not underpin CQR is consistent with our finding that
PfCRT variants are central to CQR and that PfCRT is not
an NHE homologue (Wellems et al., 1998). With regard to
QN response in the HB3 ¥ Dd2 cross, however, the pres-
Table 4. Calculations of fit for QTL model of QN response.a
Source d.f.b SSc Adj. SSd %e Ff Pg Coefh SEi
B5M86 1 44 912.6 21 227.4 3.7 7.8 0.009 -103.5 37.3
B5M74 1 36 670.5 2 131.4 0.4 0.78 0.384 32.3 36.7
pfcrt 1 214 435.8 50 650.6 8.9 18.6 0.0001 155.2 36.0
C9M57 1 25 610.2 30 975.6 5.4 11.4 0.002 118.3 35.1
C13M56 1 90 937.0 93 678.2 16.4 38.4 0.000002 198.4 33.9
B5M74 ¥ pfcrt 1 63 521.9 12 313.8 2.2 4.5 0.042 193.4 90.9
C9M57 ¥ C13M56 1 15 206.0 15 206.0 2.7 5.6 0.025 207.9 89.3
Residual 29 78 968.1
Total 36 570 262.0
a. Regression variables were coded as described previously (Kim et al., 2001).
b. One degree of freedom (d.f.) was allowed in the test of each term under type III calculations that assume that all other contributing QTL are
correct.
c. SS is the associated sum of squares.
d. Adj. SS is the adjusted sums of squares (type III sum of squares adjusting for all other terms in the model).
e. % is the total variation present in the adjusted sums of squares.
f. F-statistic is based on the adjusted sums of squares.
g. P-values derive from the F distribution.
h. Coef is the estimated effect size of the QTL. An estimated main effect of -103.5 implies that, after adjusting for all other terms in the model,
the effect of inheriting the Dd2- versus the HB3-type B5M86 marker is to decrease the QN IC90 by 103.5 nM. A pairwise interaction coefficient of
193.4 between two markers implies that the effect of a Dd2-type first marker when the second marker has the Dd2 type is to increase the QN
IC90 by 193.4 nM, compared with the effect of a Dd2-type first marker when the second marker is HB3 type.
i. SE is the standard error of this estimate.
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ence of pfnhe-1 in the Chr 13 QTL peak, along with our
observed statistical correlation in global parasite popula-
tions, could revive the possibility of a role for this gene
and its interacting QTL in Chr 9. Genetic transformation
techniques will be required to dissect the Chr 13 QTL and
to test for a role for PfNHE-1 in QN response variation.
Our studies indicate that complete dissection of these
QTL effects will require experimental designs addressing
the need to account for multiple genes from different chro-
mosomes working in combination.
As QN response is a complex trait that includes multiple
modifiers and paired interactions with other loci, a single
genetic cross may capture only a subset of the genetic
components that exist in the general population. Depend-
ing on genetic background effects associated with distinct
geographies and drug selection histories, QTL from differ-
ent regions may vary dramatically in their contributions to
the phenotype of QN response. This is consistent with
reports of candidate genes underlying certain quantitative
traits that have been difficult to dissect in other systems
(Steinmetz et al., 2002). The results of our population
survey of parasite strains from south-east Asia, Africa and
South America support a model in which multiple genes
can combine in different ways to produce similar pheno-
types of reduced QN response, as has been suggested
recently in a study using outbred parasite isolates to
examine drug response associations with transporter
gene mutations (Mu et al., 2003). Such a model incorpo-
rates a requirement for mutations in multiple loci and may
preclude jumps to clinical levels of QN resistance such as
have occurred against other antimalarial drugs as a result
of mutations in single genes. Further characterizations of
QN response determinants may provide ways to monitor
for incipient resistance in multiple loci and support action
against QN-resistant strains should they arise.
This first use of QTL mapping in P. falciparum demon-
strates how QTL mapping can provide a critical layer of
information to an integrated genomics approach for
dissecting the molecular components of complex
phenotypes. In addition to identifying loci, QTL mapping
methods can highlight the broader genetic architecture by
specifying the number of genes and the relative contribu-
tions of the specific parental alleles as well as how the
genes may be interacting. This strategy in turn provides a
context for understanding mutations in populations and for
designing appropriate functional gene manipulation
experiments.
Experimental procedures
Dose–response assays
Clones from the genetic cross between the Dd2 clone from
Indochina and the HB3 clone from Honduras (Wellems et al.,
1990) were cultivated in vitro by standard methods (Haynes
et al., 1976; Trager and Jensen, 1976). Red blood cells
(RBCs) were purified from leucocytes and platelets by Sep-
acell R-500II sets (Baxter, Fenwal Division) and suspended
in complete medium [CM; RPMI 1640 with L-glutamine (Life
Technologies), 370 mM hypoxanthine (Hx) and 25 mM
Hepes; 0.5% Albumax I (Life Technologies), 10 mg ml-1 gen-
tamicin and 0.225% NaHCO3) at 4% haematocrit. Cultures
were maintained in six-well plates at 37∞C under an atmo-
sphere of 5% CO2/5% O2/90% N2 in environmental chambers
(Billups-Rothenberg). Parasites recovered from cryopreser-
vates were cultivated for at least three cycles to ascertain
thriving growth with a minimum doubling of parasitaemia in
each 48 h period before assays. The parasite stages in these
cultures were generally synchronous as a result of ring stage-
specific survival from the freeze–thaw process. Samples for
drug assays were diluted from cultures consisting of >75%
ring stages.
Drug assays are sensitive to variations in haematocrit,
starting parasitaemia, medium constituents (especially differ-
ent sources of serum, when used), pH and parasite life cycle
stage (Bickii et al., 1998; Duraisingh et al., 1999). We mini-
mized these sources of non-heritable variation by the follow-
ing precautions: Albumax from the same lot was used as a
serum substitute; RBCs from one of two donors and CM were
prepared in bulk and used within 1 and 2 weeks respectively;
media stocks were refreshed with gas mixture daily to limit
pH variation; after smear preparation, medium was changed
and cultures were returned to gassed incubator chambers at
37∞C for 2 h before initiating tests; Dd2 and HB3 parental
lines were included in each test as internal controls; up to
nine parasite clones at carefully established parasitaemias
were tested simultaneously and housed in the same environ-
mental chamber; assays of each line were replicated on
different occasions with cultures originating from at least two
separate frozen stocks thawed several weeks apart. Drug
stocks (1 mg ml-1) of QN hydrochloride, CQ diphosphate and
VP hydrochloride were prepared in tissue culture-grade dim-
ethyl sulphoxide (DMSO) or 70% ethanol (Sigma) and pre-
served at -70∞C until use. Dilutions from these stocks were
established in modified low-hypoxanthine CM (low-Hx CM;
RPMI 1640 with L-glutamine, 2.94 mM Hx and 50 mM Hepes;
0.5% Albumax I, 10 mg ml-1 gentamicin and 0.225%
NaHCO3). Drug assays based on [3H]-hypoxanthine incorpo-
ration (Desjardins et al., 1979) were conducted in flat-
bottomed 96-well plates (Corning Life Sciences). Control
wells in each assay included: parasitized RBCs in CM without
QN, CQ or VP; unparasitized RBCs in CM; and parasitized
RBCs in CM containing 0.89 mM VP (no QN or CQ). Cells
from the wells were lysed after 64–68 h by freezing and
thawing, transferred onto glass fibre filtermats, placed in
sample bags containing scintillation fluid and counted using
a 1450 Micro beta plate reader (Perkin-Elmer Life Sciences).
Counts per minute (c.p.m.) from all test wells were adjusted
by subtracting the counts from RBC-only control wells. Per-
centage inhibition was calculated by the formula:
100 ¥ [(c.p.m. of no drug control)-(c.p.m. of treated sample)]/
(c.p.m. of no drug control).
IC50, IC90, slope values and confidence intervals (CI) were
computed from the sigmoid dose–response curves derived
from fitting a three-parameter Hill function (Hill 3 equation
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from SigmaPlot; SPSS) to the data from repeated assays. VP
chemosensitization ratios were computed from the IC50 and
IC90 values in the presence and absence of 0.89 mM VP.
Mean values used for genome scanning were calculated from
7 to 22 independent assays of each progeny clone, 65 assays
of the Dd2 parent and 53 assays of the HB3 parent.
Genome-wide scans
QTL analysis was carried out by computational approaches
described previously (Sen and Churchill, 2001). The erythro-
cyte stages of the parasites used for genotyping and pheno-
typing are haploid; consequently, only two genetic classes
are present for each locus, and the computational approach
is equivalent to an analysis of recombinant inbred lines. Pro-
grams (http://www.jax.org/research//churchill) were run under
the MATLAB package (MathWorks), and interval mapping was
carried out at the average resolution (5 cM) of the P. falci-
parum genetic linkage map (Su et al., 1999) (http://
www.ncbi.nlm.nih.gov/Malaria/Index.html). This resolution
ensured that each mapping interval closely corresponded to
a mapped microsatellite marker. Significance thresholds for
all genome scans were determined by permutation analyses
(Churchill and Doerge, 1994; Lander and Kruglyak, 1995).
Because our set of progeny showed regions of skewed
parental allele inheritance (Su et al., 1999), this permutation
analysis helped to ensure that drug response loci were not
falsely assigned to chance marker arrangements in the ped-
igree. Main QTL and corresponding mean trait values from
the primary scans were used to obtain estimates of residual
empirical thresholds (Doerge and Churchill, 1996) to search
by secondary scans for additional QTL. This secondary scan
procedure was equivalent to installing the a priori QTL as
covariates, thereby attributing a large portion of the overall
variation to these QTL and allowing for detection of additional
loci controlling the remaining variation.
Pairwise scans
To search for QTL affecting the QN phenotype only in the
context of specific variants at second loci, we performed
pairwise scans at 5 cM spacing, testing all possible pairs of
QTL locations. The likelihood calculated for each pair (two
main loci and an interaction term) was compared with that of
the null model (no pairwise effects). Significance was
assessed by permutation analysis of every pairwise combi-
nation of marker alleles. Where an interaction was identified,
a sequential series of statistical tests was performed to dis-
tinguish a true epistatic interaction from additive effects (inde-
pendent gene actions) and hitchhiking (false positives
resulting from related genotypes). These subsequent tests
used a stringent nominal (comparison-wise) cut-off
(P = 0.01).
Statistics
S-PLUS 2000 (Insightful) statistical analysis software was
used to compute correlation coefficients and linear regres-
sion analyses of phenotype relationships. An ANOVA for the
final model was conducted by incorporating into a multiple
regression all the main and interacting QTL identified by the
main, secondary and pairwise scans. F-statistics were cal-
culated from adjusted (type III) sums of squares to make
final determinations on the contribution of a QTL (or interac-
tion) in combination with all other QTL. For this analysis,
inheritance of the Dd2 parent allele was coded as +0.5 and
inheritance of the HB3 parent allele was coded as -0.5 in
the regression analysis. Accordingly, the main effect esti-
mate for any locus was taken to be the difference between
the effect of the Dd2 genotype and the HB3 genotype. Each
interaction parameter was computed from the different
effects on a main QTL of its paired Dd2- or HB3-type inter-
acting QTL.
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